Ignite Creation Date:
2024-07-17 @ 11:40 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06492304
Status:
RECRUITING
Last Update Posted:
2024-07-09
First Post:
2024-06-21
Brief Title:
A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With RelapsedRefractory Hematologic Malignancies
Sponsor:
CRISPR Therapeutics
Organization:
CRISPR Therapeutics